KOD logo Kodiak Sciences : KOD

KOD

Stock Data

$34.06

Change up

$0.09 (0.26%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Kodiak Sciences Inc is a pioneering biopharmaceutical company focused on developing innovative therapies for retinal diseases. Its flagship product, tarcocimab tedromer, is making strides in clinical studies to address conditions like wet age-related macular degeneration and diabetic macular edema. Additionally, Kodiak is exploring treatments for inflammatory retinal diseases and dry AMD with its early-stage candidates. Founded in 2009 and evolving from Oligasis, LLC, Kodiak is based in Palo Alto, California, pushing the boundaries of retinal disease treatment.

All Kodiak Sciences Articles

6 Articles